(RTTNews) -  Teva Pharmaceutical Industries Ltd. (TEVA: News ) reported third quarter net income attributable to Teva of $649 million, compared to $631 million last year. Earnings were $0.72 per share, down from $0.77 per share in the same quarter last year.

Non-GAAP net income attributable to Teva was $806 million or $0.89 per share, compared with $630 million or $0.77 per share in the third quarter of 2008.

On average, 20 analysts polled by Thomson Reuters expected the company to report earnings of $0.88 per share. Analysts' estimates typically exclude special items.
Net sales grew to $3.55 billion from $2.84 billion in the year ago quarter. Nineteen analysts estimated revenues of $3.63 billion.

The Board of Directors, at its meeting on November 2, 2009, declared a cash dividend for the third quarter of 2009 of NIS 0.60 per share or approximately 15.9 cents per share. The record date will be November 11, 2009, and the payment date will be November 26, 2009.

Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Ltd and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com